Winston & Strawn guided Court Square Capital Partners, a New York-based private equity firm, in reaching a definitive agreement to sell Advanced Diabetes Supply Group (ADSG) to Cardinal Health for $1.1 billion. This acquisition is expected to finalize in early 2025, pending customary regulatory approvals.
Winston & Strawn’s deal team was led by New York-based Craig Godshall, partner, with critical contributions from team members across multiple U.S. offices. The transaction demonstrates Winston & Strawn’s robust capabilities in managing complex cross-jurisdictional transactions in the healthcare sector.
“This transaction highlights the market’s strong demand for quality healthcare solutions delivered directly to patients’ homes,” Godshall said. “Our team’s diverse expertise was instrumental in achieving an agreement that positions ADSG for growth within Cardinal Health’s at-Home Solutions division, supporting its mission to bring advanced diabetes care directly to the patients who need it.”
The Winston & Strawn team included partners and associates from New York, Chicago, Houston, San Francisco, Washington, D.C., Los Angeles, and Dallas, reflecting the firm’s expansive reach and resources. Notable contributors included Matthew Schlosser, Banee Pachuca, Rachel Ingwer, Maria Kenny, Scott Landau, and Eleni Kouimelis, partners, as well as key associates from across Winston’s national footprint.
